(KBR) KBR - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US48242W1062
Stock:
Total Rating 33
Risk 79
Buy Signal -0.29
| Risk 5d forecast | |
|---|---|
| Volatility | 31.6% |
| Relative Tail Risk | -13.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.43 |
| Alpha | -29.67 |
| Character TTM | |
|---|---|
| Beta | 0.876 |
| Beta Downside | 0.822 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.08% |
| CAGR/Max DD | -0.19 |
EPS (Earnings per Share)
Revenue
Description: KBR KBR
KBR, Inc. provides scientific, technology, and engineering solutions to governments and commercial customers worldwide. It operates through Government Solutions and Sustainable Technology Solutions segments. The company offers research and development, advanced prototyping, acquisition support, systems engineering, cyber analytics, space domain awareness, test and evaluation, data analytics and integration, systems integration and program management, global supply chain management, operations readiness and support, and professional advisory services, as well as command, control, communications, computers, intelligence, surveillance, and reconnaissance services to defense, intelligence, space, aviation, and other programs and missions for military and other government agencies. It also operates portfolio of various proprietary process technologies for ammonia/syngas, chemical/petrochemicals, clean refining, and circular process/circular economy solutions. In addition, the company provides synergistic services, including energy security, broad-based energy transition and net-zero carbon emission solutions, high-end engineering, design and program management centered around decarbonization, energy efficiency, and environmental impact and asset optimization, as well as digitally-enabled operating and monitoring solutions. KBR, Inc. was founded in 1901 and is headquartered in Houston, Texas.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 415.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.38 > 1.0 |
| NWC/Revenue: 4.64% < 20% (prev 1.18%; Δ 3.46% < -1%) |
| CFO/TA 0.08 > 3% & CFO 524.0m > Net Income 415.0m |
| Net Debt (2.62b) to EBITDA (888.0m): 2.95 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (129.0m) vs 12m ago -3.01% < -2% |
| Gross Margin: 14.67% > 18% (prev 0.14%; Δ 1453 % > 0.5%) |
| Asset Turnover: 118.1% > 50% (prev 116.1%; Δ 2.04% > 0%) |
| Interest Coverage Ratio: 4.33 > 6 (EBITDA TTM 888.0m / Interest Expense TTM 166.0m) |
Altman Z'' 2.04
| A: 0.06 (Total Current Assets 2.05b - Total Current Liabilities 1.69b) / Total Assets 6.58b |
| B: 0.26 (Retained Earnings 1.70b / Total Assets 6.58b) |
| C: 0.11 (EBIT TTM 719.0m / Avg Total Assets 6.62b) |
| D: 0.10 (Book Value of Equity 521.0m / Total Liabilities 5.07b) |
| Altman-Z'' Score: 2.04 = BBB |
Beneish M -3.27
| DSRI: 0.78 (Receivables 1.09b/1.38b, Revenue 7.82b/7.73b) |
| GMI: 0.97 (GM 14.67% / 14.25%) |
| AQI: 0.96 (AQ_t 0.62 / AQ_t-1 0.65) |
| SGI: 1.01 (Revenue 7.82b / 7.73b) |
| TATA: -0.02 (NI 415.0m - CFO 524.0m) / TA 6.58b) |
| Beneish M-Score: -3.27 (Cap -4..+1) = AA |
What is the price of KBR shares?
As of March 04, 2026, the stock is trading at USD 40.98 with a total of 1,457,222 shares traded.
Over the past week, the price has changed by +1.44%, over one month by -1.56%, over three months by -6.02% and over the past year by -14.02%.
Over the past week, the price has changed by +1.44%, over one month by -1.56%, over three months by -6.02% and over the past year by -14.02%.
Is KBR a buy, sell or hold?
KBR has received a consensus analysts rating of 4.67.
Therefore, it is recommended to buy KBR.
- StrongBuy: 7
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KBR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.7 | 31% |
| Analysts Target Price | 53.7 | 31% |
KBR Fundamental Data Overview March 04, 2026
P/E Trailing = 12.8464
P/E Forward = 10.3627
P/S = 0.6781
P/B = 3.6041
P/EG = 0.5789
Revenue TTM = 7.82b USD
EBIT TTM = 719.0m USD
EBITDA TTM = 888.0m USD
Long Term Debt = 2.56b USD (from longTermDebt, two quarters ago)
Short Term Debt = 105.0m USD (from shortTermDebt, last quarter)
Debt = 3.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.62b USD (from netDebt column, last quarter)
Enterprise Value = 7.90b USD (5.28b + Debt 3.12b - CCE 500.0m)
Interest Coverage Ratio = 4.33 (Ebit TTM 719.0m / Interest Expense TTM 166.0m)
EV/FCF = 16.40x (Enterprise Value 7.90b / FCF TTM 482.0m)
FCF Yield = 6.10% (FCF TTM 482.0m / Enterprise Value 7.90b)
FCF Margin = 6.16% (FCF TTM 482.0m / Revenue TTM 7.82b)
Net Margin = 5.30% (Net Income TTM 415.0m / Revenue TTM 7.82b)
Gross Margin = 14.67% ((Revenue TTM 7.82b - Cost of Revenue TTM 6.67b) / Revenue TTM)
Gross Margin QoQ = 15.38% (prev 13.98%)
Tobins Q-Ratio = 1.20 (Enterprise Value 7.90b / Total Assets 6.58b)
Interest Expense / Debt = 1.44% (Interest Expense 45.0m / Debt 3.12b)
Taxrate = 26.14% (40.0m / 153.0m)
NOPAT = 531.0m (EBIT 719.0m * (1 - 26.14%))
Current Ratio = 1.22 (Total Current Assets 2.05b / Total Current Liabilities 1.69b)
Debt / Equity = 2.08 (Debt 3.12b / totalStockholderEquity, last quarter 1.50b)
Debt / EBITDA = 2.95 (Net Debt 2.62b / EBITDA 888.0m)
Debt / FCF = 5.44 (Net Debt 2.62b / FCF TTM 482.0m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.27% (Net Income 415.0m / Total Assets 6.58b)
RoE = 28.27% (Net Income TTM 415.0m / Total Stockholder Equity 1.47b)
RoCE = 17.86% (EBIT 719.0m / Capital Employed (Equity 1.47b + L.T.Debt 2.56b))
RoIC = 12.92% (NOPAT 531.0m / Invested Capital 4.11b)
WACC = 6.14% (E(5.28b)/V(8.40b) * Re(9.14%) + D(3.12b)/V(8.40b) * Rd(1.44%) * (1-Tc(0.26)))
Discount Rate = 9.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.27%
[DCF] Terminal Value 87.16% ; FCFF base≈447.6m ; Y1≈528.2m ; Y5≈812.1m
[DCF] Fair Price = 152.5 (EV 21.99b - Net Debt 2.62b = Equity 19.36b / Shares 127.0m; r=6.14% [WACC]; 5y FCF grow 19.19% → 2.90% )
EPS Correlation: 92.19 | EPS CAGR: 13.29% | SUE: 1.04 | # QB: 2
Revenue Correlation: 84.57 | Revenue CAGR: 2.57% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.93 | Chg7d=-0.054 | Chg30d=-0.054 | Revisions Net=-4 | Analysts=7
EPS current Year (2026-12-31): EPS=4.02 | Chg7d=-0.021 | Chg30d=-0.021 | Revisions Net=+0 | Growth EPS=+2.3% | Growth Revenue=+3.7%
EPS next Year (2027-12-31): EPS=4.31 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=+2 | Growth EPS=+7.1% | Growth Revenue=+5.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.4% (Discount Rate 9.1% - Earnings Yield 7.8%)
[Growth] Growth Spread = -3.7% (Analyst -2.4% - Implied 1.4%)
P/E Forward = 10.3627
P/S = 0.6781
P/B = 3.6041
P/EG = 0.5789
Revenue TTM = 7.82b USD
EBIT TTM = 719.0m USD
EBITDA TTM = 888.0m USD
Long Term Debt = 2.56b USD (from longTermDebt, two quarters ago)
Short Term Debt = 105.0m USD (from shortTermDebt, last quarter)
Debt = 3.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.62b USD (from netDebt column, last quarter)
Enterprise Value = 7.90b USD (5.28b + Debt 3.12b - CCE 500.0m)
Interest Coverage Ratio = 4.33 (Ebit TTM 719.0m / Interest Expense TTM 166.0m)
EV/FCF = 16.40x (Enterprise Value 7.90b / FCF TTM 482.0m)
FCF Yield = 6.10% (FCF TTM 482.0m / Enterprise Value 7.90b)
FCF Margin = 6.16% (FCF TTM 482.0m / Revenue TTM 7.82b)
Net Margin = 5.30% (Net Income TTM 415.0m / Revenue TTM 7.82b)
Gross Margin = 14.67% ((Revenue TTM 7.82b - Cost of Revenue TTM 6.67b) / Revenue TTM)
Gross Margin QoQ = 15.38% (prev 13.98%)
Tobins Q-Ratio = 1.20 (Enterprise Value 7.90b / Total Assets 6.58b)
Interest Expense / Debt = 1.44% (Interest Expense 45.0m / Debt 3.12b)
Taxrate = 26.14% (40.0m / 153.0m)
NOPAT = 531.0m (EBIT 719.0m * (1 - 26.14%))
Current Ratio = 1.22 (Total Current Assets 2.05b / Total Current Liabilities 1.69b)
Debt / Equity = 2.08 (Debt 3.12b / totalStockholderEquity, last quarter 1.50b)
Debt / EBITDA = 2.95 (Net Debt 2.62b / EBITDA 888.0m)
Debt / FCF = 5.44 (Net Debt 2.62b / FCF TTM 482.0m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.27% (Net Income 415.0m / Total Assets 6.58b)
RoE = 28.27% (Net Income TTM 415.0m / Total Stockholder Equity 1.47b)
RoCE = 17.86% (EBIT 719.0m / Capital Employed (Equity 1.47b + L.T.Debt 2.56b))
RoIC = 12.92% (NOPAT 531.0m / Invested Capital 4.11b)
WACC = 6.14% (E(5.28b)/V(8.40b) * Re(9.14%) + D(3.12b)/V(8.40b) * Rd(1.44%) * (1-Tc(0.26)))
Discount Rate = 9.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.27%
[DCF] Terminal Value 87.16% ; FCFF base≈447.6m ; Y1≈528.2m ; Y5≈812.1m
[DCF] Fair Price = 152.5 (EV 21.99b - Net Debt 2.62b = Equity 19.36b / Shares 127.0m; r=6.14% [WACC]; 5y FCF grow 19.19% → 2.90% )
EPS Correlation: 92.19 | EPS CAGR: 13.29% | SUE: 1.04 | # QB: 2
Revenue Correlation: 84.57 | Revenue CAGR: 2.57% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.93 | Chg7d=-0.054 | Chg30d=-0.054 | Revisions Net=-4 | Analysts=7
EPS current Year (2026-12-31): EPS=4.02 | Chg7d=-0.021 | Chg30d=-0.021 | Revisions Net=+0 | Growth EPS=+2.3% | Growth Revenue=+3.7%
EPS next Year (2027-12-31): EPS=4.31 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=+2 | Growth EPS=+7.1% | Growth Revenue=+5.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.4% (Discount Rate 9.1% - Earnings Yield 7.8%)
[Growth] Growth Spread = -3.7% (Analyst -2.4% - Implied 1.4%)